Powered By
Overview
Depakote is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control various types of seizures, including complex partial seizures and simple and complex absence seizures. Depakote… read more
Overview
Aptiom is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults who experience partial-onset seizures. Aptiom is indicated as an adjunct to existing medications when a… read more
Overview
Klonopin is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat seizure disorders. Klonopin is most often used to treat absence seizures, myoclonic seizures, and… read more
Overview
Felbatol is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of severe epilepsy in adults when other drugs cannot effectively control seizures. Since Felbatol… read more
Overview
Neurontin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in people three years of age and older. Neurontin is usually prescribed in addition to… read more
Overview
Lyrica is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in 2005 as an adjunctive medication for the treatment of partial seizures in adults and children with epilepsy. Lyrica… read more
Overview
Oxtellar XR is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in people six years of age and older. Oxtellar XR may be prescribed as monotherapy (a… read more
Overview
Zarontin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control absence (petit mal) seizures in epilepsy. Zarontin is frequently prescribed for children with childhood absence… read more
Overview
Mysoline is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control grand mal (tonic-clonic), psychomotor, and focal epileptic seizures. Mysoline is also referred to by its drug… read more
Overview
Sabril is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control spasms in infants one month to two years of age and, in combination with other medications, refractory complex… read more
Join
